Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)

Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs‪)‬

Clinical Chemistry 2006, Jan, 52, 1

    • 29,00 kr
    • 29,00 kr

Utgivarens beskrivning

Because disease-causing microorganisms can be used as aerobiological weapons, accurate and timely identification of these agents is necessary (1-4). Important agents include Bacillus anthracis (anthrax), Brucella species (brucellosis), Clostridium botulinum (botulism), Coxiella burnetii (Q fever), Francisella tularensis (tularemia), Staphylococcus aureus, and Yersinia pestis (plague) (5). Real-time PCR can rapidly detect the presence of nucleic acid markers with small reaction volumes and rapid cycling. Assay chemistry is increasingly important in this identification process because the choices and concentrations of enzymes, buffers, salts, primers, and probes affect assay detection limits (6-12). Real-time PCR assays for detecting biological warfare agents have been developed on the R.A.P.I.D.[R] (Idaho Technology, Inc.), LightCycler[R] (Roche), and Smart Cycler[R] (Cepheid) platforms and are compatible with various fluorescence-based methods such as TagMan[R] (13, 14), hybridization probes (15, 16), molecular beacons (17-19), Scorpion primers (20), LUXE primers (21-24), AEGIS primers (25-27), and SimpleProbes[R] (IT Biochem). We investigated whether these assays produce comparable sensitivity and specificity on these rapid cycling instruments.

GENRE
Vetenskap och natur
UTGIVEN
2006
1 januari
SPRÅK
EN
Engelska
LÄNGD
14
Sidor
UTGIVARE
American Association for Clinical Chemistry, Inc.
STORLEK
214,9
KB

Fler böcker av Clinical Chemistry

D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs) Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs) Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials) Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005
Inadequate Attempts to Measure the Microheterogeneity of Transthyretin by Low-Resolution Mass Spectrometry (Letters) (Letter to the Editor) Inadequate Attempts to Measure the Microheterogeneity of Transthyretin by Low-Resolution Mass Spectrometry (Letters) (Letter to the Editor)
2005